2 completed, 1 recruiting, 1 terminated, 1 withdrawn. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow AMB-05X: new trials by email Literature Review of AMB-05X trials Research Report on AMB-05X
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment AMB-05X - Colorectal Cancer | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 15 | 2024-12-04 | 2026-08-25 |
| A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis AMB-05X, Placebo - IPF | Phase 2 | Withdrawn | AmMax Bio, Inc. | 2023-03-01 | 2023-01-19 | |
| A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT AMB-05X - Pigmented Villonodular Synovitis, TGCT | Phase 2 | Completed | AmMax Bio, Inc. | 20 | 2023-01-26 | 2024-07-05 |
| A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients AMB-05X - Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis | Phase 2 | Terminated | AmMax Bio, Inc. | 4 | 2021-09-16 | 2024-05-24 |
| An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee AMB-05X - Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis (PVNS) | Phase 2 | Completed | AmMax Bio, Inc. | 11 | 2021-05-25 | 2024-06-27 |
Giant Cell Tumor of Tendon Sheath (3) · Synovitis, Pigmented Villonodular (3) · Colorectal Neoplasms (1) · Idiopathic Pulmonary Fibrosis (1)
AmMax Bio, Inc. (4) · M.D. Anderson Cancer Center (1)
United States (3) · Netherlands (2) · Poland (2) · Ukraine (2) · Australia (1) · Hungary (1)
Dorothy Nguyen, MD (4) · Van Morris, MD (1)